X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
https://www.prnewswire.com/news-releases/pfenex-and-nt-pharma-enter-into-a-development-and-license-agreement-for-pfenexs-pf708-therapeutic-equivalent-candidate-to-forteo-300632434.html
http://raps.org/Regulatory-Focus/News/2018/01/09/29156/FDA-Denies-Amneal-Petition-Seeking-to-Block-Generic-Versions-of-Osteoporosis-Treatment/?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails
https://www.prnewswire.com/news-releases/new-data-on-forteo-teriparatide-rdna-origin-injection-showed-reduced-risk-for-new-vertebral-and-clinical-fractures-in-postmenopausal-women-with-severe-osteoporosis-300553474.html
http://www.prnewswire.com/news-releases/the-indian-peptides-and-heparin-market-worth-8830-million-and-1702-million-usd-by-2022-respectively-641199763.html
https://www.pharmacompass.com/pdf/news/gedeon-richter-plc-terrosa-teriparatide-receives-approval-in-europe-1494071806.pdf
https://www.pharmacompass.com/pdf/news/stada-arzneimittel-movymia-teriparatide-receives-approval-in-europe-1489748319.pdf
https://www.pharmacompass.com/pdf/news/gedeon-richter-terrosa-teriparatide-receives-approval-in-europe-1489748686.pdf
http://www.pharmatimes.com/news/glide_raises_3.2m_for_solid_dose_injector_programme_1185653
http://www.pharmatimes.com/news/nine_therapies_put_forward_for_eu_approval_1176576
http://www.reuters.com/article/us-richter-gedeon-drug-idUSKBN1390RG
http://www.prnewswire.com/news-releases/amgen-and-ucb-present-positive-data-at-endo-2016-comparing-romosozumab-with-teriparatide-300244852.html
http://www.fiercepharmaasia.com/story/eli-lilly-could-see-another-18-months-emerging-markets-slowdown/2016-02-01
http://www.prnewswire.com/news-releases/glide-technologies-announces-successful-proof-of-concept-with-novel-exenatide-solid-dose-formulation-564345691.html
http://www.fiercepharma.com/story/lilly-falls-short-analyst-forecasts-2016-guidance-weaker-end/2016-01-05
http://cphi-online.com/novozymes-veltis-halflife-extension-technology-news038197.html
http://wwwext.amgen.com/media/media_pr_detail.jsp?releaseID=2084188
Market Place
Share 
